Acetylsalicylic acid Completed Phase 3 Trials for Systemic Embolism / Transient Ischemic Attack (TIA) / Infarction, Brain Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00235248Aortic Arch Related Cerebral Hazard Trial (ARCH)